RTÉ Ireland s National Television And Radio Broadcaster.

Lenire is a bimodal neuromodulation tool which works by supplying mild electrical pulses to the tongue, with an intra-oral part called the 'Tonguetip ®', combined with acoustic excitement through earphones to drive long-term adjustments in the brain to treat tinnitus.

Neuromod, which introduced that FDA approval at a joint defence and veteran audiology conference in the US has actually already received its initial United States order and the very first shipment from its Letterkenny-based production partner, Bookmarks Philips-Medisize, was en route today.

Given that the previous round of moneying raised in October 2020, the business has actually made progression commercialising Lenire, broadening the device's schedule throughout Europe, developing a wholly possessed US subsidiary, Neuromod USA Inc, and safeguarding United States market approval from the FDA.

The first of these tests, TENT-A1, stands for one of the biggest and longest followed-up clinical trials ever performed in the ringing in the ears area and was the cover tale for the clinical journal Scientific research Translational Medicine in October 2020.